We also attempted to investigate whether radiotherapy increased the incidence of NF1 and TP53 mutations by comparing the mutations rates between the paired primary (without radiotherapy) and recurrent (occur after radiotherapy) GBM cases from TCGA. This evidence concerns the gene NF1 and glioblastoma.